申请人:HEPTARES THERAPEUTICS LTD
公开号:WO2022129890A1
公开(公告)日:2022-06-23
The disclosures herein relate to novel compounds of formula (1): and salts thereof, wherein Y, Z, R1, R2, R3, R4, R5and n are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with H4 receptors.
本文披露了一种新型化合物的公式(1)及其盐,其中Y、Z、R1、R2、R3、R4、R5和n的定义如下,并且它们用于治疗、预防、改善、控制或减少与H4受体相关的疾病的风险。